Acadia Pharmaceuticals Inc (ACAD)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Baker Bros. Advisors

Julian Baker And Felix Baker

41,910,704 $1,081,296 +1% 4.68%
2.
VenBio Select Advisor

Kurt Von Emster

2,500,000 $64,500 +29% 1.11%
3.
D E Shaw

D. E. Shaw

2,355,208 $60,764 +6% 0.05%
4.
Palo Alto Investors

William Leland Edwards

2,337,877 $60,317 +2% 3.43%
5.
Perceptive Advisors

Joseph Edelman

1,410,305 $36,386 0.45%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$34.47 42,473 Large Shareholder, Director 38,433,977 2020-03-18 Filing
$34.47 3,837 Large Shareholder, Director 3,470,609 2020-03-18 Filing
$33.63 33,464 Large Shareholder, Director 38,391,504 2020-03-18 Filing
$33.63 3,023 Large Shareholder, Director 3,466,772 2020-03-18 Filing
$32.85 2,201 Large Shareholder, Director 38,358,040 2020-03-18 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$20.33 7,850 Officer, Director 49,312 2021-04-30 Filing
$20.33 4,230 Officer 36,434 2021-04-30 Filing
$20.33 1,054 Officer 11,371 2021-04-30 Filing
$20.33 1,032 Officer 10,553 2021-04-30 Filing
$50.61 2,051 Officer 8,340 2021-02-04 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 92,959 $2,267,270 0.01%
2. 10,590 $258,000 0%
3. 604 $14,484 0%
4. 459,812 $11,215 0.01%
5. 408,597 $9,965 0.12%
News See All